RxDoctor Payments Data

Peter Brier

Geriatric Medicine · Lemoyne, PANPI 1952392367

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Amgen at 26.8% of the total. Reporting peaked in 2019 at $1,249 and has fallen 90.0% since, to $125 in 2021.

$1,575in general payments, 2019–2025

Across 87 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$422
  • Novo Nordisk$209
  • Lilly USA, LLC$129
  • Boston Scientific$91
  • Merck$80
  • Sunovion Pharmaceuticals Inc.$80
  • plus $564 from 15 others

What the payments were for

  • Food & beverage$1,56799%
  • Education$81%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,575 in reported general payments places this provider in the 80th percentile of 217 geriatric medicine providers in Pennsylvania.

See all geriatric medicine providers in Pennsylvania

Other geriatric medicine in Lemoyne

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →